Elon Musk’s brain-implant startup, Neuralink, has received approval to begin recruiting patients for its first human trial. The company is seeking people with paralysis to test its experimental device in a six-year study.
Last year, the Food and Drug Administration denied the company’s request to fast-track human trials, but recently approved Neuralink for an investigational exemption that allows a device to be used for clinical studies. Neuralink is one of several companies developing a brain-computer interface (BCI) that can collect and analyze brain signals.
Neuralink says it is looking for patients with quadriplegia due to cervical spinal cord injury or ALS (amyotrophic lateral sclerosis). Participants will have a BCI surgically implanted in a region of the brain that controls movement, with the goal of enabling them to control a computer cursor or a keyboard using only their thoughts. The study will evaluate the safety and functionality of the technology.
No further information is available concerning upcoming details of the trial.
By Maanvi Singh Reprinted from The Guardian